ConforMIS Company Profile (NASDAQ:CFMS)

About ConforMIS (NASDAQ:CFMS)

ConforMIS logoConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Devices & Implants
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CFMS
  • CUSIP: N/A
  • Web: www.conformis.com
Capitalization:
  • Market Cap: $194.7 million
  • Outstanding Shares: 43,850,000
Average Prices:
  • 50 Day Moving Avg: $4.22
  • 200 Day Moving Avg: $5.65
  • 52 Week Range: $3.79 - $10.93
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.78
  • P/E Growth: 0.25
Sales & Book Value:
  • Annual Revenue: $80.1 million
  • Price / Sales: 2.50
  • Book Value: $1.82 per share
  • Price / Book: 2.51
Profitability:
  • EBIDTA: ($55,080,000.00)
  • Net Margins: -74.55%
  • Return on Equity: -60.57%
  • Return on Assets: -50.04%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 6.13%
  • Quick Ratio: 5.37%
Misc:
  • Average Volume: 281,854 shs.
  • Beta: 2.15
  • Short Ratio: 11.91
 

Frequently Asked Questions for ConforMIS (NASDAQ:CFMS)

What is ConforMIS's stock symbol?

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

How were ConforMIS's earnings last quarter?

ConforMIS, Inc. (NASDAQ:CFMS) announced its quarterly earnings results on Wednesday, May, 10th. The company reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.04. The business earned $20.50 million during the quarter, compared to the consensus estimate of $18.48 million. ConforMIS had a negative net margin of 74.55% and a negative return on equity of 60.57%. ConforMIS's revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.37) EPS. View ConforMIS's Earnings History.

Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?

6 equities research analysts have issued 1 year target prices for ConforMIS's shares. Their predictions range from $7.50 to $14.00. On average, they anticipate ConforMIS's share price to reach $9.90 in the next twelve months. View Analyst Ratings for ConforMIS.

Who are some of ConforMIS's key competitors?

Who are ConforMIS's key executives?

ConforMIS's management team includes the folowing people:

  • Kenneth Fallon III, Independent Chairman of the Board
  • Mark A. Augusti, President, Chief Executive Officer, Director
  • Paul S. Weiner, Chief Financial Officer
  • Daniel Steines M.D., Chief Technology Officer
  • David Cerveny, Chief Legal Officer and General Counsel
  • Philipp Lang M.D., Director
  • Bradley R. Langdale, Independent Director
  • Colm C. Lanigan, Independent Director
  • Richard J. Meelia, Independent Director
  • Michael D. Milligan, Independent Director

When did ConforMIS IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who owns ConforMIS stock?

ConforMIS's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Creative Planning (0.06%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.

Who sold ConforMIS stock? Who is selling ConforMIS stock?

ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Creative Planning. Company insiders that have sold ConforMIS stock in the last year include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner and Philipp Lang. View Insider Buying and Selling for ConforMIS.

How do I buy ConforMIS stock?

Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ConforMIS's stock price today?

One share of ConforMIS stock can currently be purchased for approximately $4.57.


MarketBeat Community Rating for ConforMIS (NASDAQ CFMS)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  108 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ConforMIS (NASDAQ:CFMS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.90 (116.63% upside)

Analysts' Ratings History for ConforMIS (NASDAQ:CFMS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/16/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
6/20/2017Oppenheimer Holdings, Inc.Reiterated RatingBuyLowView Rating Details
5/16/2017B. RileyReiterated RatingBuy$7.50LowView Rating Details
5/11/2017Canaccord GenuitySet Price TargetHold$8.00LowView Rating Details
11/4/2016J P Morgan Chase & CoReiterated RatingHold$11.00N/AView Rating Details
9/19/2016SunTrust Banks, Inc.Initiated CoverageBuy$14.00N/AView Rating Details
5/13/2016Deutsche Bank AGLower Price TargetBuy$26.00 -> $12.00N/AView Rating Details
5/13/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/1/2015Sterne Agee CRTInitiated CoverageBuy$26.00N/AView Rating Details
(Data available from 7/20/2015 forward)

Earnings

Earnings History for ConforMIS (NASDAQ:CFMS)
Earnings by Quarter for ConforMIS (NASDAQ:CFMS)
Earnings History by Quarter for ConforMIS (NASDAQ CFMS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q1 2017($0.36)($0.40)$18.48 million$20.50 millionViewN/AView Earnings Details
2/15/2017Q416($0.30)($0.37)$21.37 million$21.70 millionViewListenView Earnings Details
11/3/2016Q316($0.36)($0.31)$18.27 million$18.60 millionViewListenView Earnings Details
8/8/2016Q216($0.35)($0.34)$18.02 million$19.30 millionViewListenView Earnings Details
5/12/2016Q116($0.38)($0.37)$19.23 million$20.30 millionViewListenView Earnings Details
2/11/2016Q415($0.41)($0.37)$17.23 million$19.10 millionViewListenView Earnings Details
11/2/2015Q3($0.38)($0.45)$13.51 million$13.90 millionViewN/AView Earnings Details
8/11/2015Q215($1.31)($2.51)$11.20 million$19.20 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ConforMIS (NASDAQ:CFMS)
2017 EPS Consensus Estimate: ($1.44)
2018 EPS Consensus Estimate: ($1.36)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.38)($0.36)($0.37)
Q2 20173($0.39)($0.35)($0.37)
Q3 20173($0.37)($0.33)($0.35)
Q4 20173($0.36)($0.34)($0.35)
Q1 20181($0.34)($0.34)($0.34)
Q2 20181($0.34)($0.34)($0.34)
Q3 20181($0.34)($0.34)($0.34)
Q4 20181($0.34)($0.34)($0.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ConforMIS (NASDAQ:CFMS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for ConforMIS (NASDAQ:CFMS)
Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 39.31%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Institutional Ownership by Quarter for ConforMIS (NASDAQ:CFMS)
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/20/2017Bradley LangdaleDirectorSell6,722$4.30$28,904.60View SEC Filing  
4/26/2017Daniel SteinesInsiderSell5,000$5.54$27,700.00View SEC Filing  
4/5/2017Daniel SteinesInsiderSell5,000$5.00$25,000.00View SEC Filing  
2/15/2017Philipp LangDirectorSell137,968$8.60$1,186,524.80View SEC Filing  
2/3/2017David CervenyInsiderSell3,569$8.59$30,657.71View SEC Filing  
2/3/2017Paul S WeinerCFOSell2,676$8.42$22,531.92View SEC Filing  
2/3/2017Philipp LangDirectorSell108,705$8.60$934,863.00View SEC Filing  
1/25/2017Philipp LangDirectorSell108,985$8.60$937,271.00View SEC Filing  
1/23/2017Philipp LangDirectorSell9,681$8.60$83,256.60View SEC Filing  
1/13/2017Philipp LangDirectorSell37,275$8.60$320,565.00View SEC Filing  
1/11/2017Philipp LangDirectorSell2,800$8.62$24,136.00View SEC Filing  
1/10/2017Philipp LangDirectorSell83,909$8.64$724,973.76View SEC Filing  
1/9/2017Philipp LangDirectorSell6,200$8.65$53,630.00View SEC Filing  
1/5/2017Philipp LangDirectorSell400$8.60$3,440.00View SEC Filing  
1/3/2017Philipp LangDirectorSell74,876$8.00$599,008.00View SEC Filing  
12/30/2016Philipp LangDirectorSell168,734$8.25$1,392,055.50View SEC Filing  
12/28/2016Philipp LangDirectorSell58,547$8.26$483,598.22View SEC Filing  
12/27/2016Philipp LangDirectorSell42,086$8.57$360,677.02View SEC Filing  
12/23/2016Philipp LangDirectorSell30,647$8.62$264,177.14View SEC Filing  
10/17/2016Daniel SteinesInsiderSell889$8.64$7,680.96View SEC Filing  
10/17/2016Paul S WeinerCFOSell884$8.60$7,602.40View SEC Filing  
10/12/2016Daniel SteinesInsiderSell10,000$9.66$96,600.00View SEC Filing  
10/5/2016Philipp LangCEOSell53,860$10.19$548,833.40View SEC Filing  
10/4/2016Philipp LangCEOSell400$10.00$4,000.00View SEC Filing  
10/3/2016Daniel SteinesCTOSell10,000$10.03$100,300.00View SEC Filing  
10/3/2016Philipp LangCEOSell10,410$10.03$104,412.30View SEC Filing  
9/16/2016Daniel SteinesInsiderSell30,000$9.09$272,700.00View SEC Filing  
8/17/2016Kenneth P Fallon IIIDirectorSell4,000$8.44$33,760.00View SEC Filing  
5/17/2016Robert Law IIISVPBuy1,600$6.20$9,920.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for ConforMIS (NASDAQ:CFMS)
Latest Headlines for ConforMIS (NASDAQ:CFMS)
Source:
DateHeadline
globenewswire.com logoConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - GlobeNewswire (press release)
globenewswire.com - July 20 at 4:21 AM
finance.yahoo.com logoConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017
finance.yahoo.com - July 19 at 6:17 PM
americanbankingnews.com logoComparing Uroplasty (UPI) & ConforMIS (NASDAQ:CFMS)
www.americanbankingnews.com - July 19 at 9:34 AM
americanbankingnews.com logoSt Jude Medical (STJ) versus ConforMIS (CFMS) Head-To-Head Survey
www.americanbankingnews.com - July 19 at 8:51 AM
americanbankingnews.com logoBTIG Research Reiterates "Hold" Rating for ConforMIS, Inc. (CFMS)
www.americanbankingnews.com - July 18 at 12:56 AM
americanbankingnews.com logoFinancial Comparison: ConforMIS (CFMS) and St Jude Medical (STJ)
www.americanbankingnews.com - July 17 at 2:31 PM
americanbankingnews.com logo$19.40 Million in Sales Expected for ConforMIS, Inc. (NASDAQ:CFMS) This Quarter
www.americanbankingnews.com - July 14 at 4:24 PM
americanbankingnews.com logoConforMIS, Inc. (CFMS) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - July 12 at 7:10 PM
globenewswire.com logoConforMIS Names Dan Krupp Senior Vice President US Sales - GlobeNewswire (press release)
globenewswire.com - July 12 at 5:42 PM
americanbankingnews.com logo Brokerages Expect ConforMIS, Inc. (NASDAQ:CFMS) Will Post Earnings of -$0.36 Per Share
www.americanbankingnews.com - July 12 at 8:30 AM
americanbankingnews.com logoZacks Investment Research Lowers ConforMIS, Inc. (CFMS) to Sell
www.americanbankingnews.com - July 11 at 10:52 PM
finance.yahoo.com logoETFs with exposure to ConforMIS, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 6:08 PM
finance.yahoo.com logoConforMIS Names Dan Krupp Senior Vice President U.S. Sales
finance.yahoo.com - July 11 at 6:08 PM
americanbankingnews.com logoConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 10:59 AM
finance.yahoo.com logoETFs with exposure to ConforMIS, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 4:56 PM
americanbankingnews.com logoRTI Surgical (RTIX) vs. ConforMIS (CFMS) Head to Head Contrast
www.americanbankingnews.com - June 25 at 12:17 PM
americanbankingnews.com logoConforMIS, Inc. (CFMS) Director Sells $28,904.60 in Stock
www.americanbankingnews.com - June 22 at 8:16 PM
americanbankingnews.com logoConforMIS, Inc. (CFMS) Given "Buy" Rating at Oppenheimer Holdings, Inc.
www.americanbankingnews.com - June 21 at 11:22 PM
streetinsider.com logoConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System - StreetInsider.com
www.streetinsider.com - June 20 at 9:55 PM
americanbankingnews.com logoConforMIS, Inc. (CFMS) Research Coverage Started at BTIG Research
www.americanbankingnews.com - June 20 at 5:30 PM
streetinsider.com logoConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System
www.streetinsider.com - June 20 at 4:53 PM
finance.yahoo.com logoConforMIS Announces FDA 510(k) Clearance for iTotal Hip System
finance.yahoo.com - June 20 at 4:53 PM
americanbankingnews.com logo$19.40 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter
www.americanbankingnews.com - June 18 at 10:00 AM
americanbankingnews.com logoConforMIS (CFMS) versus HeartWare International (HTWR) Financial Analysis
www.americanbankingnews.com - June 16 at 10:48 PM
finance.yahoo.com logoETFs with exposure to ConforMIS, Inc. : June 16, 2017
finance.yahoo.com - June 16 at 5:00 PM
americanbankingnews.com logo Analysts Anticipate ConforMIS, Inc. (CFMS) to Post -$0.36 EPS
www.americanbankingnews.com - June 16 at 8:46 AM
finance.yahoo.com logoConforMIS, Inc. :CFMS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 4:59 PM
americanbankingnews.com logoFinancial Comparison: Glaukos Corporation (GKOS) and ConforMIS (CFMS)
www.americanbankingnews.com - June 13 at 10:35 PM
streetinsider.com logoConforMIS Inc (CFMS) Announces Publication of Study Comparing Customized Knee Replacement Implants to Off-the ... - StreetInsider.com
www.streetinsider.com - June 13 at 3:48 PM
finance.yahoo.com logoConforMIS Announces the Publication of Clinical and Economic Study Comparing Customized Total Knee Replacement Implants to Off-the-Shelf Total Knee Replacement Implants
finance.yahoo.com - June 13 at 12:44 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 6 at 8:42 AM
americanbankingnews.com logoAnalyzing RTI Surgical (RTIX) & ConforMIS (CFMS)
www.americanbankingnews.com - June 6 at 12:06 AM
americanbankingnews.com logoConforMIS Inc (CFMS) Expected to Announce Earnings of -$0.36 Per Share
www.americanbankingnews.com - May 19 at 1:20 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Given "Buy" Rating at B. Riley
www.americanbankingnews.com - May 16 at 6:58 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 15 at 10:16 PM
americanbankingnews.com logoAnalysts Issue Forecasts for ConforMIS Inc's Q2 2017 Earnings (CFMS)
www.americanbankingnews.com - May 15 at 7:58 AM
americanbankingnews.com logoOppenheimer Holdings Comments on ConforMIS Inc's Q2 2017 Earnings (CFMS)
www.americanbankingnews.com - May 15 at 7:58 AM
americanbankingnews.com logoConforMIS's (CFMS) "Buy" Rating Reaffirmed at B. Riley
www.americanbankingnews.com - May 14 at 9:36 AM
americanbankingnews.com logoConforMIS Inc (CFMS) Given a $8.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - May 13 at 6:58 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 12 at 8:48 AM
finance.yahoo.com logoEdited Transcript of CFMS earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - May 11 at 9:54 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Given a $9.00 Price Target at Oppenheimer Holdings Inc.
www.americanbankingnews.com - May 11 at 2:56 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - May 11 at 12:44 AM
finance.yahoo.com logoConforMIS reports 1Q loss
finance.yahoo.com - May 10 at 9:26 PM
finance.yahoo.com logoInvestor Network: ConforMIS Inc to Host Earnings Call
finance.yahoo.com - May 10 at 4:26 PM
finance.yahoo.com logoConforMIS Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 10 at 4:26 PM
americanbankingnews.com logoConforMIS (CFMS) Getting Somewhat Favorable Press Coverage, Analysis Finds
www.americanbankingnews.com - May 4 at 9:17 AM
americanbankingnews.com logoConforMIS (CFMS) Earning Somewhat Negative News Coverage, AlphaOne Reports
www.americanbankingnews.com - May 1 at 4:26 PM
americanbankingnews.com logoConforMIS Inc (CFMS) Expected to Announce Quarterly Sales of $18.4 Million
www.americanbankingnews.com - April 30 at 9:16 AM
americanbankingnews.com logoConforMIS Inc (CFMS) Insider Daniel Steines Sells 5,000 Shares
www.americanbankingnews.com - April 29 at 1:23 AM

Social

Chart

ConforMIS (CFMS) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by MarketBeat.com Staff